These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


455 related items for PubMed ID: 26725307

  • 21. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
    Ayhan A, Al RA, Baykal C, Demirtas E, Ayhan A, Yüce K.
    Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
    [Abstract] [Full Text] [Related]

  • 22. Results of radical surgery in women with stage IB2/IIA2 cervical cancer.
    Derks M, Biewenga P, van der Velden J, Kenter GG, Stalpers LJ, Buist MR.
    Acta Obstet Gynecol Scand; 2016 Feb; 95(2):166-72. PubMed ID: 26575692
    [Abstract] [Full Text] [Related]

  • 23. [Impact on survival and quality of life of laparoscopic radical hysterectomy and pelvic lymphadenectomy to patients with early-stage cervical cancer].
    Yang ZJ, Chen YL, Yao DS, Zhang JQ, Li F, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):854-9. PubMed ID: 22333237
    [Abstract] [Full Text] [Related]

  • 24. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
    van de Lande J, von Mensdorff-Pouilly S, Lettinga RG, Piek JM, Verheijen RH.
    Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
    Kasamatsu T, Onda T, Sawada M, Kato T, Ikeda S.
    Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
    Denschlag D, Gabriel B, Mueller-Lantzsch C, Tempfer C, Henne K, Gitsch G, Hasenburg A.
    Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
    [Abstract] [Full Text] [Related]

  • 30. Comparison between conventional surgery plus postoperative adjuvant radiotherapy and concurrent chemoradiation for FIGO stage IIB cervical carcinoma: a retrospective study.
    Yamashita H, Okuma K, Kawana K, Nakagawa S, Oda K, Yano T, Kobayashi S, Wakui R, Ohtomo K, Nakagawa K.
    Am J Clin Oncol; 2010 Dec; 33(6):583-6. PubMed ID: 20065848
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
    Contreras J, Srivastava A, Chundury A, Schwarz JK, Markovina S, Thaker PH, Massad LS, Mutch DG, Powell MA, Grigsby PW, Lin AJ.
    Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
    [Abstract] [Full Text] [Related]

  • 33. Do FIGO stage IA and small (≤2 cm) IB1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery?
    Al-Kalbani M, McVeigh G, Nagar H, McCluggage WG.
    Int J Gynecol Cancer; 2012 Feb; 22(2):291-5. PubMed ID: 22080884
    [Abstract] [Full Text] [Related]

  • 34. Perineural space invasion in cervical cancer (FIGO IB1-IIB) accompanied by high-risk factors for recurrence.
    Skręt-Magierło JE, Soja PJ, Skręt A, Kruczek A, Kaznowska E, Wicherek Ł.
    J Cancer Res Ther; 2014 Feb; 10(4):957-61. PubMed ID: 25579536
    [Abstract] [Full Text] [Related]

  • 35. Surgical treatment of microinvasive cervical cancer: analysis of pathologic features with implications on radicality.
    Yoneda JY, Braganca JF, Sarian LO, Borba PP, Conceição JC, Zeferino LC.
    Int J Gynecol Cancer; 2015 May; 25(4):694-8. PubMed ID: 25742569
    [Abstract] [Full Text] [Related]

  • 36. Early stage cervical cancer with negative pelvic lymph nodes: pattern of failure and complication following radical hysterectomy and adjuvant radiotherapy.
    Chen SW, Liang JA, Yang SN, Lin FJ.
    Eur J Gynaecol Oncol; 2004 May; 25(1):81-6. PubMed ID: 15053068
    [Abstract] [Full Text] [Related]

  • 37. Prognostic factors that affect survival after the treatment of early stage cervical carcinoma.
    Atasii T, Aksu MF, Cetinkaya MB.
    Int Surg; 2000 May; 85(2):147-51. PubMed ID: 11071333
    [Abstract] [Full Text] [Related]

  • 38. Isolated full-thickness cervical stromal invasion warrants post-hysterectomy pelvic radiotherapy in FIGO stages IB-IIA uterine cervical carcinoma.
    Moon SH, Wu HG, Ha SW, Lee HP, Kang SB, Song YS, Park NH, Kim JW, Park IA, Kim BH.
    Gynecol Oncol; 2007 Jan; 104(1):152-7. PubMed ID: 16935323
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.